﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/us-fda-issues-emergency-use-authorisation-for-mercks-molnupiravir-10923</loc><lastmod>2021-12-24T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/indian-pharmaceutical-market-grew-at-66-pc-in-november-10924</loc><lastmod>2021-12-24T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/novavax-and-sk-bioscience-expand-manufacturing-agreement-10925</loc><lastmod>2021-12-24T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/granules-india-appoints-sucharita-rao-palepu-as-non-executive-independent-director-10926</loc><lastmod>2021-12-24T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/biocon-partner-equillium-initiates-clinical-study-for-itolizumab-in-lupus-nephritis-10927</loc><lastmod>2021-12-24T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/lecanemab-granted-fast-track-designation-by-the-us-fda-10928</loc><lastmod>2021-12-24T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/cansinobios-convidecia-vaccine-largely-effective-against-covid-19-in-phase-iii-trial-10929</loc><lastmod>2021-12-24T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>